Find Thiazolidine-4-Carboxylic Acid manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Thiazolidine-4-carboxylic acid, 444-27-9, 1,3-thiazolidine-4-carboxylic acid, Detoxepa, Hepalidine, Thioproline
Molecular Formula
C4H7NO2S
Molecular Weight
133.17  g/mol
InChI Key
DZLNHFMRPBPULJ-UHFFFAOYSA-N
FDA UNII
E5913T3IBL

Thiazolidine-4-Carboxylic Acid
Timonacic is a cyclic sulfur amino acid derivative with potential antineoplastic and antioxidant activities. Acting on cellular membranes of malignant cells through an unknown mechanism, timonacic may induce malignant cells to revert back to an untransformed state. This agent may also restore contact inhibition, a phenomenon characterized by the paracrine inhibition of mitosis following the formation of a critical cell mass, presumably the result of cell-to-cell signal transfer. Timonacic may also produce antioxidant effects secondary to its release of cysteine and restoration of glutathione concentrations.
1 2D Structure

Thiazolidine-4-Carboxylic Acid

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1,3-thiazolidine-4-carboxylic acid
2.1.2 InChI
InChI=1S/C4H7NO2S/c6-4(7)3-1-8-2-5-3/h3,5H,1-2H2,(H,6,7)
2.1.3 InChI Key
DZLNHFMRPBPULJ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1C(NCS1)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
E5913T3IBL
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Gamma-thiaproline

2. Heparegen

3. Norgamem

4. Thiaproline

5. Thiazolidine-4-carboxylic Acid

6. Thiazolidine-4-carboxylic Acid, (r)-isomer

7. Thiazolidine-4-carboxylic Acid, Sodium Salt

8. Thioproline

2.3.2 Depositor-Supplied Synonyms

1. Thiazolidine-4-carboxylic Acid

2. 444-27-9

3. 1,3-thiazolidine-4-carboxylic Acid

4. Detoxepa

5. Hepalidine

6. Thioproline

7. 4-thiazolidinecarboxylic Acid

8. Tiazolidin

9. Heparegene

10. Norgamem

11. Thiaproline

12. L-thiazolidine-4-carboxylic Acid

13. Dl-thiaproline

14. 4-carboxythiazolidine

15. Norgamen

16. Usaf C-1

17. T-4ca

18. Timonacic [inn]

19. Heptaladine

20. Timonacicum

21. Hepaldine

22. Heparegen

23. Timonacico

24. Usaf A-3701

25. Dl-thiazolidinecarboxylic Acid

26. Hepacom

27. Nsc 25855

28. Nsc-25855

29. Acide Thiazolidine-4-carboxylique

30. Thiazolidinecarboxylic Acid

31. Acide Dl Thiazolidine Carboxylique-4

32. Mfcd00128958

33. E5913t3ibl

34. Chebi:64564

35. Timonacic (inn)

36. Nsc25855

37. 4-thiazolidinecarboxylic Acid, L-

38. Timonacicum [inn-latin]

39. Timonacico [inn-spanish]

40. Thiazolidinecarboxylic Acid (van)

41. Einecs 207-146-6

42. Einecs 242-945-3

43. 4-thiazolidinecarboxylicacid

44. Thiazolidin

45. Unii-e5913t3ibl

46. Thiazolidine-4-carboxylicacid

47. Acide Thiazolidine-4-carboxylique [french]

48. Ccris 8099

49. Acide Dl Thiazolidine Carboxylique-4 [french]

50. L-4-thiazolidinecarboxylic Acid, 98%

51. Pidotimod Impurity

52. Hepacom (tn)

53. Timonacic [mi]

54. Timonacic [inci]

55. Timonacic [mart.]

56. 4-thiazolidincarboxylic Acid

57. Schembl8356

58. Timonacic [who-dd]

59. H-d-thz-oh;d-thioproline

60. Wln: T5m Cstj Evq

61. Thiazolidine-4-caboxylic Acid

62. Thiazolidin-4-carboxylic Acid

63. Chembl358722

64. Dtxsid9023675

65. Wln: T5m Cstj Evq -l

66. Dl-thiazolidine-4-carboxylic Acid

67. Hms3264c18

68. Pharmakon1600-01503320

69. Act03153

70. Albb-005988

71. Bcp13616

72. Hy-b1169

73. 1,3-thiazolidane-4-carboxylic Acid

74. Nsc758453

75. S4993

76. Stk361805

77. Akos000119343

78. Akos016040292

79. Racemic Thiazolidine-4-carboxylic Acid

80. 1,3-thiazolidine-4-carboxylic Acid #

81. Ab03779

82. Am81428

83. Ccg-213875

84. Cs-8024

85. Db12856

86. Nsc-758453

87. As-13539

88. Sbi-0207087.p001

89. 4-thiazolidinecarboxylic Acid, (.+/-.)-

90. Db-048659

91. Bb 0254773

92. Ft-0639201

93. Ft-0653153

94. Ft-0675152

95. Ft-0679172

96. A18785

97. D08601

98. D97373

99. Ab01563202_01

100. (r)-thiazolidine-4-carboxylic Acid;l-thioproline

101. 592t477

102. A876895

103. Ah-232/20359048

104. L(-)-thiazolidine-4-carboxylic Acid;l-thiaproline

105. Sr-01000944258

106. Sr-01000944258-1

107. Q23637400

108. Z955123540

109. 60731-25-1

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 133.17 g/mol
Molecular Formula C4H7NO2S
XLogP3-2.3
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count1
Exact Mass133.01974964 g/mol
Monoisotopic Mass133.01974964 g/mol
Topological Polar Surface Area74.6 Ų
Heavy Atom Count8
Formal Charge0
Complexity106
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antidotes

Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)


Antineoplastic Agents

Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)


Antioxidants

Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)


Anti-Arrhythmia Agents

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty